This study looks at the long-term safety and effectiveness of a drug called verekitug for adults with severe asthma. It includes 396 people who already finished the earlier VALIANT study. Researchers will track side effects and how often asthma attacks happen over time.
Phase: PHASE2 • Sponsor: Upstream Bio Inc. • Aim: Disease control
Last updated May 15, 2026 11:54 UTC